C. Vilos

Molecular Biology · 2014

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom C. Vilos trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. H. Maeda

Papers from C. Vilos's perspective

Ordered by how strongly the researchers C. Vilos trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile (Science Translational Medicine)
  2. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging (Proceedings of the National Academy of Sciences of the United States of America)
  3. The ErbB receptors and their role in cancer progression. (Experimental Cell Research)
  4. Role of target geometry in phagocytosis. (Proceedings of the National Academy of Sciences of the United States of America)
  5. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells (Nature)
  6. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles (Proceedings of the National Academy of Sciences of the United States of America)
  7. Challenges and key considerations of the enhanced permeability and retention (EPR) effect for nanomedicine drug delivery in oncology (Cancer Research)
  8. The golden age: gold nanoparticles for biomedicine (Chemical Society Reviews)
  9. Multifunctional dendritic polymers in nanomedicine: opportunities and challenges. (Chemical Society Reviews)
  10. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. (Accounts of Chemical Research)

Their papers